| Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study YY Liu, Y Wang, TR Walsh, LX Yi, R Zhang, J Spencer, Y Doi, G Tian, ... The Lancet infectious diseases 16 (2), 161-168, 2016 | 3471 | 2016 |
| 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides Y Doi, Y Arakawa Clinical Infectious Diseases 45 (1), 88-94, 2007 | 583 | 2007 |
| Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens ZA Qureshi, DL Paterson, BA Potoski, MC Kilayko, G Sandovsky, ... Antimicrobial agents and chemotherapy 56 (4), 2108-2113, 2012 | 544 | 2012 |
| PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron N Shibata, Y Doi, K Yamane, T Yagi, H Kurokawa, K Shibayama, H Kato, ... Journal of Clinical Microbiology 41 (12), 5407-5413, 2003 | 456 | 2003 |
| The global epidemiology of carbapenemase-producing Enterobacteriaceae D van Duin, Y Doi Virulence 8 (4), 460-469, 2017 | 403 | 2017 |
| Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa K Yokoyama, Y Doi, K Yamane, H Kurokawa, N Shibata, K Shibayama, ... The Lancet 362 (9399), 1888-1893, 2003 | 368 | 2003 |
| Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States Y Doi, YS Park, JI Rivera, JM Adams-Haduch, A Hingwe, EM Sordillo, ... Clinical Infectious Diseases 56 (5), 641-648, 2013 | 321 | 2013 |
| Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance ZA Qureshi, LE Hittle, JA O'Hara, JI Rivera, A Syed, RK Shields, ... Clinical infectious diseases 60 (9), 1295-1303, 2015 | 281 | 2015 |
| Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides Y Doi, K Yokoyama, K Yamane, J Wachino, N Shibata, T Yagi, ... Antimicrobial agents and chemotherapy 48 (2), 491-496, 2004 | 281 | 2004 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 274 | 2017 |
| Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections RK Shields, BA Potoski, G Haidar, B Hao, Y Doi, L Chen, EG Press, ... Clinical Infectious Diseases 63 (12), 1615-1618, 2016 | 268 | 2016 |
| Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections RK Shields, L Chen, S Cheng, KD Chavda, EG Press, A Snyder, ... Antimicrobial agents and chemotherapy 61 (3), 2017 | 258 | 2017 |
| Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clinical Infectious Diseases 66 (2), 163-171, 2018 | 254 | 2018 |
| Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli T Yagi, J Wachino, H Kurokawa, S Suzuki, K Yamane, Y Doi, N Shibata, ... Journal of Clinical Microbiology 43 (6), 2551-2558, 2005 | 230 | 2005 |
| Procalcitonin-guided use of antibiotics for lower respiratory tract infection DT Huang, DM Yealy, MR Filbin, AM Brown, CCH Chang, Y Doi, ... New England Journal of Medicine 379 (3), 236-249, 2018 | 226 | 2018 |
| Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia RK Shields, MH Nguyen, L Chen, EG Press, BA Potoski, RV Marini, Y Doi, ... Antimicrobial agents and chemotherapy 61 (8), 2017 | 218 | 2017 |
| Acinetobacter baumannii: evolution of antimicrobial resistance—treatment options Y Doi, GL Murray, AY Peleg Seminars in respiratory and critical care medicine 36 (1), 85, 2015 | 218 | 2015 |
| Coproduction of novel 16S rRNA methylase RmtD and metallo-β-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil Y Doi, D de Oliveira Garcia, J Adams, DL Paterson Antimicrobial agents and chemotherapy 51 (3), 852-856, 2007 | 213 | 2007 |
| Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania JM Adams-Haduch, DL Paterson, HE Sidjabat, AW Pasculle, BA Potoski, ... Antimicrobial agents and chemotherapy 52 (11), 3837-3843, 2008 | 209 | 2008 |
| Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study Y Wang, GB Tian, R Zhang, Y Shen, JM Tyrrell, X Huang, H Zhou, L Lei, ... The Lancet infectious diseases 17 (4), 390-399, 2017 | 205 | 2017 |
